Immunogenetic and immunologic markers of early rheumatoid arthritis. RADIKAL program first stage results

Immunogenetic and immunologic markers of early rheumatoid arthritis. RADIKAL program first stage results

Objective. To assess frequency of immunogenetic (HLA-DRB I allels) and immunologic - anti-cyclic citrullinated peptide antibodies (ACCP), IgM rheumatoid factor (RF) - parameters and their significance as markers of early rheumatoid arthritis (RA). Material and methods. HLA-DRB 1 alleles, ACCP and Ig...

Full description

Saved in:

Bibliographic Details
Main Authors:	I A Guseva, N V Demidova, E L Luchihina, A A Novikov, E N Alexandrova, M N Boldyreva, I A Guskova, D E Karateev, E L Nasonov
Format:	Article
Language:	Russian
Published:	IMA PRESS LLC 2008-12-01
Series:	Научно-практическая ревматология
Subjects:	shared epitope (se) rheumatoid arthritis hla-drb 1 allele anti-cyclic citrullinated peptide antibodies (accp) rheumatoid factor (rf)
Online Access:	https://rsp.mediar-press.net/rsp/article/view/624
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relationship of immunogenetic and immunologic markers and their influence on disease activity and radiological progression in patients with early rheumatoid arthritis
by: N V Demidova
Published: (2009-06-01)

HLA-DRB1 allele distribution in Chilean population: insights into rheumatoid arthritis susceptibility and protection
by: Diego Catalán, et al.
Published: (2025-05-01)

Autologous Tolerogenic Dendritic Cells for Rheumatoid Arthritis-2 (AuToDeCRA-2) study: protocol for a single-centre, experimental medicine study investigating the route of delivery and potential efficacy of autologous tolerogenic dendritic cell (TolDC) therapy for rheumatoid arthritis
by: Ema-Louise Long, et al.
Published: (2025-08-01)

ACCP-negative rheumatoid arthritis – clinical and immunological features
by: D. A. Dibrov
Published: (2022-07-01)

Prevalence and significance of anti-citrullinated cyclic peptide antibodies in relapsing polychondritis
by: Damien Sène, et al.
Published: (2025-06-01)

Anti-carbamylated protein antibodies in ACCP-negative and ACCP-positive patients with rheumatoid arthritis
by: D. A. Dibrov, et al.
Published: (2024-01-01)

Frequency and diagnostic significance of anti-cyclic citrullinated peptide antibodies (ACCP) and anti-modified citrullinated vimentin antibodies (AMCV) in children with early juvenile arthritis
by: S O Salugina, et al.
Published: (2008-12-01)

Genomic Evolution of the SARS-CoV-2 Omicron Variant in Córdoba, Argentina (2021–2022): Analysis of Uncommon and Prevalent Spike Mutations
by: Nadia B. Olivero, et al.
Published: (2024-12-01)

HLA-DRB1 alleles in patients with rheumatoid arthritis
by: L A Taukumova, et al.
Published: (2004-08-01)

INVESTIGATION OF CANDIDATE GENE POLYMORPHISMS IN AN IMMUNE RESPONSE AS MARKERS FOR THE RISK OF DEVELOPING RHEUMATOID ARTHRITIS AND PRODUCING AUTOANTIBODIES
by: I. A. Guseva, et al.
Published: (2016-03-01)

Clinical features of ACPA-negative and ACPA-positive variants of rheumatoid arthritis
by: D. A. Dibrov, et al.
Published: (2023-04-01)

Bone destruction in rheumatoid arthritis: role of autoantibodies
by: Anastasia Sergeyevna Avdeyeva, et al.
Published: (2013-06-01)

Rheumatoid arthritis as a clinical and immunological syndrome: focus on the seronegative subtype of the disease
by: E. L. Nasonov, et al.
Published: (2023-06-01)

TRENDS IN DISEASE ACTIVITY, FUNCTIONAL STATUS, AND RADIOGRAPHIC CHANGES IN EARLY RHEUMATOID ARTHRITIS: RESULTS OF A 5-YEAR FOLLOW-UP WITHIN THE RUSSIAN RADIKAL PROGRAM
by: Yu. A. Ermakova, et al.
Published: (2015-03-01)

Early arthritis in children – first results of prospective follow up
by: S. O. Salugina, et al.
Published: (2016-05-01)

Immunogenetic characteristics of potential donors of hemapoietic stem cells recruited in the North Caucasus
by: M. A. Loginova, et al.
Published: (2021-03-01)

RHEUMATOID FACTOR AND ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN PATIENTS WITH PSORIATIC ARTHRITIS
by: V. V. Badokin, et al.
Published: (2011-06-01)

A systematic review of T cell epitopes defined from the proteome of human immunodeficiency virus
by: Yan Ding, et al.
Published: (2025-08-01)

The INVOLVEMENT OF HLA-DRB1*11 AND HLA-DRB1*12 ALLELES IN THE OCCURRENCE OF DENGUE FEVER IN BURKINA FASO
by: Lassina TRAORE, et al.
Published: (2024-12-01)

An allelic atlas of immunoglobulin heavy chain variable regions reveals antibody binding epitope preference resilient to SARS-CoV-2 mutation escape
by: Weiqi Deng, et al.
Published: (2025-01-01)

CLINICAL CHARACTERISTICS OF THREE COHORTS OF PATIENTS WITH EARLY- AND LATE-ONSET RHEUMATOID ARTHRITIS (AT 50 YEARS OR OLDER). GENERALIZATION OF 40 YEARS’ EXPERIENCE
by: A. M. Satybaldyev, et al.
Published: (2020-04-01)

THE CLINICAL AND DIAGNOSTIC VALUE OF ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODIES IN EARLY JUVENILEARTHRITIS
by: S O Salugina, et al.
Published: (2009-06-01)

The roles of anti-citrullinated protein antibodies in the immunopathogenesis of rheumatoid arthritis
by: Hui-Chun Yu, et al.
Published: (2019-01-01)

TIME COURSE OF CHANGES IN LABORATORY BIOMARKERS IN PATIENTS WITH RHEUMATOID ARTHRITIS DURING TOCILIZUMAB THERAPY
by: E N Aleksandrova, et al.
Published: (2011-06-01)

The rs7574865 polymorphism of the <i>STAT4</i> gene and risk of early rheumatoid arthritis development (the REMARKA study)
by: I. A. Guseva, et al.
Published: (2019-03-01)

THE 2016 EULAR GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF EARLY ARTHRITIS
by: E. L. Nasonov
Published: (2017-04-01)

Rheumatoid factor and antibodies against cyclic citrullinated peptide in patients without rheumatoid arthritis
by: N. V. Bunchuk
Published: (2023-01-01)

Seropositive juvenile rheumatoid arthritis: analysis of the spectrum of clinical manifestations and therapy according to a retrospective study
by: М. I. Kaleda, et al.
Published: (2021-02-01)

Different clinical relevance of anti-citrullinated proteins antibodies in RA patients
by: A. S. Avdeeva, et al.
Published: (2022-05-01)

Consumer motivations for participation in the sharing economy: A goal-framing perspective
by: João Miguel O. Cotrim, et al.
Published: (2025-06-01)

Predicting the development of rheumatoid arthritis in patients with early undifferentiated arthritis
by: E L Luchihina, et al.
Published: (2009-04-01)

Cerebrovascular reactivity depending on rheumatoid factor and anticitrullinated protein antibody positivity in hypertensive patients with rheumatoid arthritis
by: N. V. Rebrova, et al.
Published: (2022-07-01)

Bone resorption during therapy with denosumab in patients with rheumatoid arthritis, positive for the main immunological markers
by: P. S. Kovalenko, et al.
Published: (2022-11-01)

Integrated in-silico design and in vivo validation of multi-epitope vaccines for norovirus
by: Jingxuan Qiu, et al.
Published: (2025-05-01)

Comparative Analysis of Rheumatoid Factor Levels by Immune Turbidimetry and Latex Agglutination Assays among Anti-Cyclic Citrullinated Peptide-Positive Rheumatoid Arthritis Patients
by: Bineeta Kashyap, et al.
Published: (2020-10-01)

Anti-cyclic citrullinated peptide antibodies – a role in rheumatoid arthritis and the possibility of seroconversion: A focus on abatacept
by: N. V. Chichasova
Published: (2017-03-01)

Predominant T-cell epitopes of SARS-CoV-2 restricted by multiple prevalent HLA-B and HLA-C allotypes in Northeast Asia
by: Yu Zhao, et al.
Published: (2025-05-01)

Klinicheskaya znachimost' opredeleniya HLA-DRB1-genotipov, assotsiirovannykh s predraspolozhennost'yu ili ustoychivost'yu k sakharnomu diabetu 1 tipa, v razlichnykh etnicheskikh gruppakh Rossii
by: L P Alekseev, et al.
Published: (2007-06-01)

AUTOANTIBODIES TO CIRTULLINATED ANTIGENS FOR DIAGNOSIS AND PREDICTION OF CLINICAL COURSE IN EARLY RHEUMATOID ARTHRITIS
by: I. B. Belyaeva, et al.
Published: (2014-07-01)

Donor – recipient selection using epitope mismatches in kidney transplantation
by: A. V. Vatazin, et al.
Published: (2021-01-01)